Peptide questions · Bofanglutide

How long does bofanglutide take to work?

Reviewed Evidence: ModeratePublished by PepVault

Bofanglutide’s onset is days–2 weeks, its peak effect comes at 52 weeks (phase 3 endpoint), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

The timeline’s basis: Phase 1 (Liu 2025, Diabetes Obes Metab), phase 2b (Ji 2026, Signal Transduct Target Ther; NCT06256562), Gan & Lee releases Jun-12-2026 (GRADUAL-1, US phase 2) and Nov-4-2026 (GRADUAL-3), registry records. Investigational.

Bofanglutide week by week

The library places five of its research notes on bofanglutide on the days they cover, from day 1 to day 364 and on: 5 on randomized trials.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The bofanglutide notes by day
WhenThe noteEvidence
Days 1–28 (weeks 1–4)Three milligrams, the first stepRandomized trial
Days 29–210 (weeks 5–30)Twelve milligrams every two weeksRandomized trial
Days 57–364 (weeks 9–52)Twenty-four milligrams, a phase 3 doseRandomized trial
Days 85–364 (weeks 13–52)The top doseRandomized trial
From day 365 onOne shot a month to hold itRandomized trial
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track bofanglutide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The bofanglutide timeline’s milestones

The library’s timeline for bofanglutide marks 5 points from week 1 to week 76, backed by moderate evidence overall.

  • Week 1: Commonly reported: appetite dropping in the first days on 3 mg
  • Week 2: Its trials stepped the dose up every 2 to 4 weeks from 3 mg
  • Week 30: Phase 2b endpoint: about 10% (12 mg) to 16% (48 mg) average loss every 2 weeks vs about 1% on placebo
  • Week 52: Phase 3 GRADUAL-1: about 15% (24 mg) and 18.5% (48 mg) vs about 1% on placebo
  • Week 76: GRADUAL-3: after the switch to one shot a month, weight held for 24 weeks

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why bofanglutide takes that long

Bofanglutide’s half-life is about 7 days (168 hours), so one dose is about 96.9% cleared after 35 days.

The library’s frequency for bofanglutide (“Every 2 weeks (or weekly)”) isn’t one fixed interval, so this page computes no build-up for it.

The notes on bofanglutide follow the trials’ dose steps, 3mg, 12mg, 24mg and 48mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

Bofanglutide against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 25 metabolic & GLP-1 compounds, bofanglutide among them; 17 of the others share its onset of days–2 weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
MariTideDays–2 weeks52 weeks (phase 2 endpoint, no plateau yet)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
BofanglutideDays–2 weeks52 weeks (phase 3 endpoint)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people
L-Carnitine (injectable)Hours (blood levels rise)12–24 weeks (muscle carnitine, in the one long trial)
Tesofensine1–2 weeks (appetite falls)12–24 weeks (weight loss in the trial)

Questions people ask

How long does bofanglutide take to work?

Bofanglutide’s onset is days–2 weeks, its peak effect comes at 52 weeks (phase 3 endpoint), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

When does bofanglutide reach its peak effect?

By the library’s timeline, bofanglutide’s peak effect comes at 52 weeks (phase 3 endpoint), backed by moderate evidence.

How long is bofanglutide usually run?

The library’s timeline gives bofanglutide’s typical duration as ongoing; its cycle note says: Used continuously in its trials: every 2 weeks for 30 to 52 weeks, with steps every 2 to 4 weeks.

What does the library say about the first days on bofanglutide?

Its first note on bofanglutide, for days 1–28 (weeks 1–4), is “Three milligrams, the first step”, resting on randomized trials.

More on bofanglutide

Track it in the app

PepVault for iPhone

Track bofanglutide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo